本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NeuBase Therapeutics Inc.

0.3780
+0.0000
成交量:- -
成交額:- -
市值:141.81萬
市盈率:-0.03
高:0.3780
開:0.3780
低:0.3780
收:0.3780
資料載入中...
2025/01/07

重要事件披露

Form 8-K - Current report
2024/06/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/27

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/22

重要事件披露

Form 8-K - Current report
2024/05/16

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/03

重要事件披露

Form 8-K - Current report
2024/04/05

重要事件披露

Form 8-K - Current report
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/17

重要事件披露

Form 8-K - Current report
2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report